Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 211 articles:
HTML format

Single Articles

    January 2022
  1. ZHU C, Zhong L, Lin M, Tian C, et al
    The value of TI-RADS combined with superb micro-vascular imagine in distinguishing benign and malignant thyroid nodules: A meta-analysis.
    PLoS One. 2022;17:e0261521.
    PubMed     Abstract available

  2. WANG SW, Chan LP, Wang LF, Wu CW, et al
    Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.
    PLoS One. 2022;17:e0263773.
    PubMed     Abstract available

  3. KANAMARLAPUDI V, Tamaddon-Jahromi S, Murphy K
    ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.
    PLoS One. 2022;17:e0263845.
    PubMed     Abstract available

  4. MORNA MT, Tuoyire DA, Jimah BB, Eliason S, et al
    Prevalence and characterization of asymptomatic thyroid nodules in Assin North District, Ghana.
    PLoS One. 2022;17:e0263365.
    PubMed     Abstract available

  5. SUZUKI S, Toyoma S, Kawasaki Y, Yamada T, et al
    Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0262549.
    PubMed     Abstract available

  6. ZHANG X, Lee VCS, Rong J, Liu F, et al
    Multi-channel convolutional neural network architectures for thyroid cancer detection.
    PLoS One. 2022;17:e0262128.
    PubMed     Abstract available

  7. VERYASKINA YA, Titov SE, Ivanov MK, Ruzankin PS, et al
    Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer.
    PLoS One. 2022;17:e0254304.
    PubMed     Abstract available

  8. HO SY, Kao WC, Hsiao SY, Chiu SF, et al
    Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.
    PLoS One. 2022;17:e0266678.
    PubMed     Abstract available

  9. ABUSALAH MAH, Irekeola AA, Hanim Shueb R, Jarrar M, et al
    Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0266893.
    PubMed     Abstract available

  10. SHENG S, Su W, Mao D, Li C, et al
    MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0267017.
    PubMed     Abstract available

  11. ROUMANS CAM, Spaander MCW, Lansdorp-Vogelaar I, Biermann K, et al
    A personalized and dynamic risk estimation model: The new paradigm in Barrett's esophagus surveillance.
    PLoS One. 2022;17:e0267503.
    PubMed     Abstract available

  12. BADRI P, Baracos V, Ganatra S, Lai H, et al
    Retrospective study of factors associated with late detection of oral cancer in alberta: A qualitative study.
    PLoS One. 2022;17:e0266558.
    PubMed     Abstract available

  13. RIBEIRO-ROTTA RF, Rosa EA, Milani V, Dias NR, et al
    The cost of oral cancer: A systematic review.
    PLoS One. 2022;17:e0266346.
    PubMed     Abstract available

  14. ELLIS BG, Whitley CA, Triantafyllou A, Gunning PJ, et al
    Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    PLoS One. 2022;17:e0266043.
    PubMed     Abstract available

  15. XIE L, Shang Z
    Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.
    PLoS One. 2022;17:e0265950.
    PubMed     Abstract available

  16. ALI A, Rumbold AR, Kapellas K, Lassi ZS, et al
    Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
    PLoS One. 2022;17:e0265840.
    PubMed     Abstract available

  17. ZHANG ZJ, Shi LL, Hong XH, Xiao BY, et al
    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
    PLoS One. 2022;17:e0265551.
    PubMed     Abstract available

  18. NIK JAAFAR NR, Hamdan NA, Abd Hamid N, Rajandram RK, et al
    Posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients.
    PLoS One. 2022;17:e0265502.
    PubMed     Abstract available

  19. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed     Abstract available

  20. GRASS JK, Kusters N, Kemper M, Tintrup J, et al
    Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
    PLoS One. 2022;17:e0265093.
    PubMed     Abstract available

  21. BROUWER AF, Campredon LP, Walline HM, Marinelli BM, et al
    Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.
    PLoS One. 2022;17:e0268104.
    PubMed     Abstract available

  22. MIAO L, Lv X, Huang C, Li P, et al
    Long-term oncological outcomes after oral cancer surgery using propofol-based total intravenous anesthesia versus sevoflurane-based inhalation anesthesia: A retrospective cohort study.
    PLoS One. 2022;17:e0268473.
    PubMed     Abstract available

  23. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    PubMed     Abstract available

  24. ADNAN Y, Ali SMA, Awan MS, Idress R, et al
    Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
    PLoS One. 2022;17:e0267300.
    PubMed     Abstract available

  25. ZHANG Z, Leong Bin Abdullah MFI, Shari NI, Lu P, et al
    Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life.
    PLoS One. 2022;17:e0267887.
    PubMed     Abstract available

  26. BLATT S, Kruger M, Rump C, Zimmer S, et al
    Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0269136.
    PubMed     Abstract available

  27. KOSKINEN A, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
    PLoS One. 2022;17:e0268922.
    PubMed     Abstract available

  28. HU C, Fan J, He G, Dong C, et al
    Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0269166.
    PubMed     Abstract available

  29. TANG Q, Pan W, Peng L
    Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
    PLoS One. 2022;17:e0269995.
    PubMed     Abstract available

  30. LIANG Y, Huang X, Song Z, Yang Y, et al
    Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8th staging criteria.
    PLoS One. 2022;17:e0269994.
    PubMed     Abstract available

  31. DU Q, Xiao RD, Luo RG, Xie JB, et al
    Construction of long non-coding RNA- and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer.
    PLoS One. 2022;17:e0269742.
    PubMed     Abstract available

  32. UEDA T, Yumii K, Urabe Y, Chikuie N, et al
    Swallowing function after transoral surgery for laryngopharyngeal cancer.
    PLoS One. 2022;17:e0270509.
    PubMed     Abstract available

    January 2021
  33. MATSUOKA Y, Al-Shareef H, Kogo M, Nakahara H, et al
    Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro.
    PLoS One. 2021;16:e0212323.
    PubMed     Abstract available

  34. HE L, Zhao W, Xia Z, Su A, et al
    Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: Systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0243864.
    PubMed     Abstract available

  35. CHIANG TE, Lin YC, Wu CT, Yang CY, et al
    Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.
    PLoS One. 2021;16:e0244740.
    PubMed     Abstract available

  36. VERZA FA, Valente VB, Oliveira LK, Kayahara GM, et al
    Social isolation stress facilitates chemically induced oral carcinogenesis.
    PLoS One. 2021;16:e0245190.
    PubMed     Abstract available

  37. WANG C, Lin M, Zhong L, Tian C, et al
    The value of TI-RADS combined with superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis.
    PLoS One. 2021;16:e0245035.
    PubMed     Abstract available

  38. CHUANG FC, Wang CC, Chen JH, Hwang TZ, et al
    PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
    PLoS One. 2021;16:e0245715.
    PubMed     Abstract available

  39. CHAMBARA N, Liu SYW, Lo X, Ying M, et al
    Diagnostic performance evaluation of different TI-RADS using ultrasound computer-aided diagnosis of thyroid nodules: An experience with adjusted settings.
    PLoS One. 2021;16:e0245617.
    PubMed     Abstract available

  40. MOHAMMADI N, Alimohammadian M, Feizesani A, Poustchi H, et al
    The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: An analysis of 49,946 cases in the Golestan Cohort Study, Iran.
    PLoS One. 2021;16:e0246004.
    PubMed     Abstract available

  41. MILANI V, Zara ALSA, da Silva EN, Cardoso LB, et al
    Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
    PLoS One. 2021;16:e0246475.
    PubMed     Abstract available

  42. CHENG PC, Chang CM, Liao LJ, Cheng PW, et al
    The outcomes and decision-making process for neck lymph nodes with indeterminate fine-needle aspiration cytology.
    PLoS One. 2021;16:e0246437.
    PubMed     Abstract available

  43. WALLANDER K, Eisfeldt J, Lindblad M, Nilsson D, et al
    Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    PLoS One. 2021;16:e0245488.
    PubMed     Abstract available

  44. EVEN C, Sagaon Teyssier L, Pointreau Y, Temam S, et al
    Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
    PLoS One. 2021;16:e0246252.
    PubMed     Abstract available

  45. LIU CH, Chang JT, Lee TH, Chang PY, et al
    Total plaque score helps to determine follow-up strategy for carotid artery stenosis progression in head and neck cancer patients after radiation therapy.
    PLoS One. 2021;16:e0246684.
    PubMed     Abstract available

  46. HUTAJULU SH, Howdon D, Taroeno-Hariadi KW, Hardianti MS, et al
    Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.
    PLoS One. 2021;16:e0246638.
    PubMed     Abstract available

  47. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed     Abstract available

  48. NANNAPANENI S, Griffith CC, Magliocca KR, Chen W, et al
    Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0247498.
    PubMed     Abstract available

  49. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    PubMed     Abstract available

  50. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available

  51. AL-SALAM S, Sharma C, Abu Sa'a MT, Afandi B, et al
    Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
    PLoS One. 2021;16:e0247807.
    PubMed     Abstract available

  52. AMRENOVA A, Suzuki K, Saenko V, Yamashita S, et al
    Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.
    PLoS One. 2021;16:e0249059.
    PubMed     Abstract available

  53. SHRIDHAR K, Aggarwal A, Rawal I, Gupta R, et al
    Feasibility of investigating the association between bacterial pathogens and oral leukoplakia in low and middle income countries: A population-based pilot study in India.
    PLoS One. 2021;16:e0251017.
    PubMed     Abstract available

  54. LORENZATTI HILES G, Chang KP, Bellile EL, Wang CI, et al
    Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    PLoS One. 2021;16:e0250530.
    PubMed     Abstract available

  55. YAGYUU T, Funayama N, Imada M, Kirita T, et al
    Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
    PLoS One. 2021;16:e0250359.
    PubMed     Abstract available

  56. LEE PY, Lai JN, Chiu LT, Wei YT, et al
    Incidence and time trends of herpes zoster among patients with head and neck cancer who did and did not undergo radiotherapy: A population-based cohort study.
    PLoS One. 2021;16:e0250724.
    PubMed     Abstract available

  57. BAE YJ, Kim TE, Choi BS, Jeong WJ, et al
    Comprehensive assessments of the open mouth dynamic maneuver and metal artifact reduction algorithm on computed tomography images of the oral cavity and oropharynx.
    PLoS One. 2021;16:e0248696.
    PubMed     Abstract available

  58. SHIN YJ, Vu H, Lee JH, Kim HD, et al
    Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
    PLoS One. 2021;16:e0248167.
    PubMed     Abstract available

  59. CAMPOS-DELGADO DU, Gutierrez-Navarro O, Salinas-Martinez R, Duran E, et al
    Blind deconvolution estimation by multi-exponential models and alternated least squares approximations: Free-form and sparse approach.
    PLoS One. 2021;16:e0248301.
    PubMed     Abstract available

  60. ZHEN J, Song Z, Su W, Zeng QC, et al
    Integrated analysis of RNA-binding proteins in thyroid cancer.
    PLoS One. 2021;16:e0247836.
    PubMed     Abstract available

  61. HOSHINO I, Ishige F, Iwatate Y, Gunji H, et al
    Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0248016.
    PubMed     Abstract available

  62. SHIMADA Y, Matsubayashi J, Saito A, Ohira T, et al
    Small RNA sequencing to differentiate lung squamous cell carcinomas from metastatic lung tumors from head and neck cancers.
    PLoS One. 2021;16:e0248206.
    PubMed     Abstract available

  63. HAN S, Jin S, Yoo SH, Lee HS, et al
    A practical individualized radiation precaution based on the dose rate at release time after inpatient 131I ablation therapy.
    PLoS One. 2021;16:e0251627.
    PubMed     Abstract available

  64. SASAKI F, Kanmura S, Oda K, Maeda H, et al
    Acetaldehyde breath test as a cancer risk marker in patients with esophageal and hypopharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0251457.
    PubMed     Abstract available

  65. WANG B, Tang D, Liu Z, Wang Q, et al
    LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.
    PLoS One. 2021;16:e0251797.
    PubMed     Abstract available

  66. PAO TH, Chen YY, Chang WL, Chang JS, et al
    Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0251811.
    PubMed     Abstract available

  67. HU Y, Ai LS, Zhou LQ
    Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251202.
    PubMed     Abstract available

  68. ZHOU Y, Tian M, Gungor C, Wang D, et al
    Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis.
    PLoS One. 2021;16:e0251555.
    PubMed     Abstract available

  69. RANKOVIC N, Todorovic J, Simic R
    Clinical and ultrasound characteristics of pediatric lateral neck masses.
    PLoS One. 2021;16:e0251563.
    PubMed     Abstract available

  70. CHANG SW, Tsai YH, Hsu CM, Huang EI, et al
    Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    PLoS One. 2021;16:e0251455.
    PubMed     Abstract available

  71. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    PubMed     Abstract available

  72. CHEONG TY, Hong SD, Jung KW, So YK, et al
    The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size.
    PLoS One. 2021;16:e0251446.
    PubMed     Abstract available

  73. JIANG Y, Zhang C, Shen W, Li Y, et al
    Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
    PLoS One. 2021;16:e0255479.
    PubMed     Abstract available

  74. MATSUNAGA H, Orita M, Taira Y, Takamura N, et al
    Risk perception of the pre-distribution of stable iodine to guardians of children living around the Genkai Nuclear Power Plant, Saga Prefecture, Japan.
    PLoS One. 2021;16:e0250570.
    PubMed     Abstract available

  75. YOON JK, Jang JY, An YS, Lee SJ, et al
    Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    PLoS One. 2021;16:e0254844.
    PubMed     Abstract available

  76. GEENS M, Stappers S, Konings H, De Winter BY, et al
    Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
    PLoS One. 2021;16:e0252646.
    PubMed     Abstract available

  77. YU G, Yu W, Xu X, Ye B, et al
    Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
    PLoS One. 2021;16:e0252829.
    PubMed     Abstract available

  78. LIN S, Liu T, Chen J, Li G, et al
    Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis.
    PLoS One. 2021;16:e0252751.
    PubMed     Abstract available

  79. FANG L, Shi L, Wang W, Wu X, et al
    Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer.
    PLoS One. 2021;16:e0253545.
    PubMed     Abstract available

  80. MIARI R, Azzam N, Bar-Shalom R, Fares F, et al
    5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.
    PLoS One. 2021;16:e0253756.
    PubMed     Abstract available

  81. LEE H, Paeng JC, Choi H, Cho SW, et al
    Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration.
    PLoS One. 2021;16:e0256727.
    PubMed     Abstract available

  82. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
    Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
    PLoS One. 2021;16:e0253893.
    PubMed     Abstract available

  83. PAN XB, Huang ST, Qu S, Chen KH, et al
    Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma.
    PLoS One. 2021;16:e0253424.
    PubMed     Abstract available

  84. DE C FERREIRA C, Dufloth R, de Carvalho AC, Reis RM, et al
    Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma.
    PLoS One. 2021;16:e0253418.
    PubMed     Abstract available

  85. KIM HB, Kim GJ, Han KD, Joo YH, et al
    Changes in metabolic syndrome status and risk of laryngeal cancer: A nationwide cohort study.
    PLoS One. 2021;16:e0252872.
    PubMed     Abstract available

  86. SHINOHARA Y, Washio J, Kobayashi Y, Abiko Y, et al
    Hypoxically cultured cells of oral squamous cell carcinoma increased their glucose metabolic activity under normoxic conditions.
    PLoS One. 2021;16:e0254966.
    PubMed     Abstract available

  87. ALLEN DZ, Aljabban J, Silverman D, McDermott S, et al
    Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis.
    PLoS One. 2021;16:e0258187.
    PubMed     Abstract available

  88. BOHLAND M, Tharun L, Scherr T, Mikut R, et al
    Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis.
    PLoS One. 2021;16:e0257635.
    PubMed     Abstract available

  89. MEYER TJ, Gerhard-Hartmann E, Lodes N, Scherzad A, et al
    Pilot study on the value of Raman spectroscopy in the entity assignment of salivary gland tumors.
    PLoS One. 2021;16:e0257470.
    PubMed     Abstract available

  90. CUI Y, Kim HS, Cho ES, Han D, et al
    Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
    PLoS One. 2021;16:e0256979.
    PubMed     Abstract available

  91. MUNSAMY Y, Seedat RY, Sekee TR, Bester PA, et al
    Complete genome sequence of a HPV31 isolate from laryngeal squamous cell carcinoma and biological consequences for p97 promoter activity.
    PLoS One. 2021;16:e0252524.
    PubMed     Abstract available

  92. SCHUON R, Schwarzensteiner J, Paasche G, Lenarz T, et al
    Functional aspects of the Eustachian tube by means of 3D-modeling.
    PLoS One. 2021;16:e0244909.
    PubMed     Abstract available

  93. DICKEY BL, Sirak B, Martin-Gomez L, Reich RR, et al
    Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    PLoS One. 2021;16:e0254161.
    PubMed     Abstract available

  94. TAKENAKA Y, Takemoto N, Oya R, Inohara H, et al
    Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis.
    PLoS One. 2021;16:e0259288.
    PubMed     Abstract available

  95. MEIER V, Czichon F, Walsh L, Rohrer Bley C, et al
    Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
    PLoS One. 2021;16:e0259112.
    PubMed     Abstract available

  96. SHI Y, Zhang Y, Niu Y, Chen Y, et al
    Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis.
    PLoS One. 2021;16:e0257425.
    PubMed     Abstract available

  97. DENNING SK, Valleau MA, Pelowski WJ, Chaisson CM, et al
    An automatic water-occluding device to enable laryngectomee participation in water activities.
    PLoS One. 2021;16:e0257463.
    PubMed     Abstract available

  98. PLOYPETCH S, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Salivary proteomics in monitoring the therapeutic response of canine oral melanoma.
    PLoS One. 2021;16:e0256167.
    PubMed     Abstract available

  99. KIM TY, Lee JY, Lee YJ, Park DW, et al
    CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
    PLoS One. 2021;16:e0255835.
    PubMed     Abstract available

  100. STAIRS DB, Landmesser ME, Aliaga C, Chen KM, et al
    Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide.
    PLoS One. 2021;16:e0259998.
    PubMed     Abstract available

  101. ARORA C, Kaur D, Naorem LD, Raghava GPS, et al
    Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway.
    PLoS One. 2021;16:e0259534.
    PubMed     Abstract available

  102. TAMIN S, Adham M, Noer A, Supriana N, et al
    Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation.
    PLoS One. 2021;16:e0261110.
    PubMed     Abstract available

  103. WU CN, Wu SC, Chen WC, Yang YH, et al
    Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study.
    PLoS One. 2021;16:e0260772.
    PubMed     Abstract available

  104. YAO C, Li Y, Luo L, Xiong Q, et al
    Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
    PLoS One. 2021;16:e0260353.
    PubMed     Abstract available

  105. YOSHIDA K, Kodama Y, Tanaka Y, Pak K, et al
    Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients.
    PLoS One. 2021;16:e0260026.
    PubMed     Abstract available

  106. LIM YJ, Kong M
    Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma.
    PLoS One. 2021;16:e0259384.
    PubMed     Abstract available

  107. LIU KYP, Zhu SY, Harrison A, Chen ZY, et al
    Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma.
    PLoS One. 2021;16:e0259529.
    PubMed     Abstract available

  108. GOVINDARAJ PK, Kallarakkal TG, Mohd Zain R, Tilakaratne WM, et al
    Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).
    PLoS One. 2021;16:e0261575.
    PubMed     Abstract available

  109. KANETAKE H, Kato-Kogoe N, Terada T, Kurisu Y, et al
    Short communication: Distribution of phospholipids in parotid cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry.
    PLoS One. 2021;16:e0261491.
    PubMed     Abstract available

  110. YOON J, Choi Y, Jang J, Shin NY, et al
    Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
    PLoS One. 2021;16:e0261233.
    PubMed     Abstract available

  111. FAHEY PP, Page A, Astell-Burt T, Stone G, et al
    Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time.
    PLoS One. 2021;16:e0261416.
    PubMed     Abstract available

    January 2020
  112. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Abstract available

  113. NIU K, Guo C, Teng S, Zhou D, et al
    Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.
    PLoS One. 2020;15:e0227408.
    PubMed     Abstract available

  114. PARK VY, Han K, Kim HJ, Lee E, et al
    Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma.
    PLoS One. 2020;15:e0227315.
    PubMed     Abstract available

  115. BJERKLI IH, Jetlund O, Karevold G, Karlsdottir A, et al
    Characteristics and prognosis of primary treatment-naive oral cavity squamous cell carcinoma in Norway, a descriptive retrospective study.
    PLoS One. 2020;15:e0227738.
    PubMed     Abstract available

  116. LEVY HC, Hulvey D, Adamson-Small L, Jn-Simon N, et al
    Improved cell-specificity of adeno-associated viral vectors for medullary thyroid carcinoma using calcitonin gene regulatory elements.
    PLoS One. 2020;15:e0228005.
    PubMed     Abstract available

  117. JENG MJ, Sharma M, Chao TY, Li YC, et al
    Multiclass classification of autofluorescence images of oral cavity lesions based on quantitative analysis.
    PLoS One. 2020;15:e0228132.
    PubMed     Abstract available

  118. NGUYEN CTK, Sawangarun W, Mandasari M, Morita KI, et al
    AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression.
    PLoS One. 2020;15:e0222689.
    PubMed     Abstract available

  119. EVERS C, Ostheimer C, Sieker F, Vordermark D, et al
    Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments.
    PLoS One. 2020;15:e0229266.
    PubMed     Abstract available

  120. PANG X, Fan HY, Tang YL, Wang SS, et al
    Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
    PLoS One. 2020;15:e0229089.
    PubMed     Abstract available

  121. CAO H, He Q, Eyben RV, Bloomstein J, et al
    The role of Glial cell derived neurotrophic factor in head and neck cancer.
    PLoS One. 2020;15:e0229311.
    PubMed     Abstract available

  122. NAIR S, Trummell HQ, Rajbhandari R, Thudi NK, et al
    Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
    PLoS One. 2020;15:e0229077.
    PubMed     Abstract available

  123. O'KEEFE RA, Bhola NE, Lee DS, Johnson DE, et al
    Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.
    PLoS One. 2020;15:e0227261.
    PubMed     Abstract available

  124. RICHARD MA, Lupo PJ, Morton LM, Yasui YA, et al
    Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    PLoS One. 2020;15:e0228887.
    PubMed     Abstract available

  125. TCHEANDJIEU C, Cordina-Duverger E, Mulot C, Baron-Dubourdieu D, et al
    Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia.
    PLoS One. 2020;15:e0228187.
    PubMed     Abstract available

  126. FADHIL RS, Wei MQ, Nikolarakos D, Good D, et al
    Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0221779.
    PubMed     Abstract available

  127. YOON JH, Han K, Lee E, Lee J, et al
    Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
    PLoS One. 2020;15:e0228968.
    PubMed     Abstract available

  128. MA F, Gu X, Liu JQ, Mo LH, et al
    Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
    PLoS One. 2020;15:e0229272.
    PubMed     Abstract available

  129. GONDHOWIARDJO SA, Handoko, Adham M, Rachmadi L, et al
    Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer.
    PLoS One. 2020;15:e0230449.
    PubMed     Abstract available

  130. VIDIRI A, Gangemi E, Ruberto E, Pasqualoni R, et al
    Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
    PLoS One. 2020;15:e0229611.
    PubMed     Abstract available

  131. WALCZYK A, Kopczynski J, Gasior-Perczak D, Palyga I, et al
    Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
    PLoS One. 2020;15:e0229264.
    PubMed     Abstract available

  132. AL-SALAM S, Sharma C, Afandi B, Al Dahmani K, et al
    BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
    PLoS One. 2020;15:e0231341.
    PubMed     Abstract available

  133. HIRSHOREN N, Yoeli R, Cohen JE, Weinberger JM, et al
    Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.
    PLoS One. 2020;15:e0231038.
    PubMed     Abstract available

  134. HOEFNAGEL SJM, Mostafavi N, Timmer MR, Lau CT, et al
    A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
    PLoS One. 2020;15:e0231419.
    PubMed     Abstract available

  135. PLATEK A, Mix M, Chowdhry V, Farrugia M, et al
    Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
    PLoS One. 2020;15:e0231042.
    PubMed     Abstract available

  136. FREDERIKSEN K, Krag AE, Larsen JB, Kiil BJ, et al
    Remote ischemic preconditioning does not influence lectin pathway protein levels in head and neck cancer patients undergoing surgery.
    PLoS One. 2020;15:e0230411.
    PubMed     Abstract available

  137. IBUKI Y, Nishiyama Y, Tsutani Y, Emi M, et al
    Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    PLoS One. 2020;15:e0231116.
    PubMed     Abstract available

  138. BHALLA S, Kaur H, Kaur R, Sharma S, et al
    Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
    PLoS One. 2020;15:e0231629.
    PubMed     Abstract available

  139. ZHANG J, Zhang X, Meng Y, Chen Y, et al
    Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis.
    PLoS One. 2020;15:e0231775.
    PubMed     Abstract available

  140. YOSHIDA R, Nagata M, Hirosue A, Kawahara K, et al
    Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method.
    PLoS One. 2020;15:e0231656.
    PubMed     Abstract available

  141. JUNG HK, Tae CH, Lee HA, Lee H, et al
    Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
    PLoS One. 2020;15:e0231456.
    PubMed     Abstract available

  142. PEROT P, Falguieres M, Arowas L, Laude H, et al
    Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients.
    PLoS One. 2020;15:e0232138.
    PubMed     Abstract available

  143. MATSUDA S, Mafune A, Kohda N, Hama T, et al
    Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0231932.
    PubMed     Abstract available

  144. HAN B, Yang X, Zhang P, Zhang Y, et al
    DNA methylation biomarkers for nasopharyngeal carcinoma.
    PLoS One. 2020;15:e0230524.
    PubMed     Abstract available

  145. LI S, Peng L, Tan C, Zeng X, et al
    Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
    PLoS One. 2020;15:e0232240.
    PubMed     Abstract available

  146. LOPETUSO LR, Severgnini M, Pecere S, Ponziani FR, et al
    Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
    PLoS One. 2020;15:e0231789.
    PubMed     Abstract available

  147. HUANG CC, Lin YH, Kittipayak S, Hwua YS, et al
    Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model.
    PLoS One. 2020;15:e0232480.
    PubMed     Abstract available

  148. DE SOUZA REIS R, Gatta G, de Camargo B
    Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.
    PLoS One. 2020;15:e0232416.
    PubMed     Abstract available

  149. KEEK S, Sanduleanu S, Wesseling F, de Roest R, et al
    Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    PLoS One. 2020;15:e0232639.
    PubMed     Abstract available

  150. MENEZES FDS, Latorre MDRDO, Conceicao GMS, Curado MP, et al
    The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    PLoS One. 2020;15:e0232871.
    PubMed     Abstract available

  151. KARSTENS KF, Kempski J, Giannou AD, Freiwald E, et al
    Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.
    PLoS One. 2020;15:e0231833.
    PubMed     Abstract available

  152. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available

  153. SANDBLOM V, Spetz J, Shubbar E, Montelius M, et al
    Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
    PLoS One. 2020;15:e0233720.
    PubMed     Abstract available

  154. SAKAI A, Ando M, Fukusumi T, Ren S, et al
    Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
    PLoS One. 2020;15:e0233380.
    PubMed     Abstract available

  155. SUBHI O, Schulten HJ, Bagatian N, Al-Dayini R, et al
    Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
    PLoS One. 2020;15:e0234566.
    PubMed     Abstract available

  156. DICKINSON A, Saraswat M, Syrjanen S, Tohmola T, et al
    Comparing serum protein levels can aid in differentiating HPV-negative and -positive oropharyngeal squamous cell carcinoma patients.
    PLoS One. 2020;15:e0233974.
    PubMed     Abstract available

  157. SINGH R, Das S, Datta S, Mazumdar A, et al
    Study of Caspase 8 mutation in oral cancer and adjacent precancer tissues and implication in progression.
    PLoS One. 2020;15:e0233058.
    PubMed     Abstract available

  158. DALHAMMAR K, Malmstrom M, Schelin M, Falkenback D, et al
    The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study.
    PLoS One. 2020;15:e0235045.
    PubMed     Abstract available

  159. ORTIZ-COMINO L, Fernandez-Lao C, Speksnijder CM, Lozano-Lozano M, et al
    Upper body motor function and swallowing impairments and its association in survivors of head and neck cancer: A cross-sectional study.
    PLoS One. 2020;15:e0234467.
    PubMed     Abstract available

  160. PARK KA, Eum SY, Oh H, Cho MH, et al
    Factors affecting online health community participation behavior in patients with thyroid cancer.
    PLoS One. 2020;15:e0235056.
    PubMed     Abstract available

  161. WANG X, Zhu J, Li Z, Wei T, et al
    The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer.
    PLoS One. 2020;15:e0234843.
    PubMed     Abstract available

  162. YANG CY, Tsao CH, Hsieh CC, Lin CK, et al
    Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    PLoS One. 2020;15:e0236101.
    PubMed     Abstract available

  163. SHI S, Huang X, Ma X, Zhu X, et al
    Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
    PLoS One. 2020;15:e0225290.
    PubMed     Abstract available

  164. ZSCHAECK S, Li Y, Lin Q, Beck M, et al
    Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    PLoS One. 2020;15:e0236841.
    PubMed     Abstract available

  165. WU ZH, Fang M, Zhou Y
    Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0236678.
    PubMed     Abstract available

  166. GARMAN KS, Ajayi TA, Boutte HJ Jr, Chiu ST, et al
    Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma.
    PLoS One. 2020;15:e0235906.
    PubMed     Abstract available

  167. KALISZEWSKI K, Diakowska D, Wojtczak B, Rudnicki J, et al
    Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
    PLoS One. 2020;15:e0236257.
    PubMed     Abstract available

  168. KOIKE K, Dehari H, Ogi K, Shimizu S, et al
    Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
    PLoS One. 2020;15:e0237465.
    PubMed     Abstract available

  169. WITKIEWICZ J, Klimza H, Piersiala K, Jackowska J, et al
    The usefulness of the narrow band imaging (NBI) in decision-making process regarding second look procedure (SL) in laryngeal cancer follow-up after transoral laser microsurgery.
    PLoS One. 2020;15:e0236623.
    PubMed     Abstract available

  170. LIN FC, Chang WL, Chiang NJ, Lin MY, et al
    Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy.
    PLoS One. 2020;15:e0237114.
    PubMed     Abstract available

  171. CHEN YH, Lin CR, Liang WA, Huang CY, et al
    Motor control integrated into muscle strengthening exercises has more effects on scapular muscle activities and joint range of motion before initiation of radiotherapy in oral cancer survivors with neck dissection: A randomized controlled trial.
    PLoS One. 2020;15:e0237133.
    PubMed     Abstract available

  172. THOMAS S, Carroll JC, Brown MC, Chen Z, et al
    Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis.
    PLoS One. 2020;15:e0237723.
    PubMed     Abstract available

  173. LIN NC, Hsu JT, Tsai KY
    Survival and clinicopathological characteristics of different histological grades of oral cavity squamous cell carcinoma: A single-center retrospective study.
    PLoS One. 2020;15:e0238103.
    PubMed     Abstract available

  174. YOON JH, Jeon MJ, Kim M, Hong AR, et al
    Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
    PLoS One. 2020;15:e0238207.
    PubMed     Abstract available

  175. SAKAI A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, et al
    Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment.
    PLoS One. 2020;15:e0238120.
    PubMed     Abstract available

  176. ANWAR N, Pervez S, Chundriger Q, Awan S, et al
    Oral cancer: Clinicopathological features and associated risk factors in a high risk population presenting to a major tertiary care center in Pakistan.
    PLoS One. 2020;15:e0236359.
    PubMed     Abstract available

  177. SABA NF, Dinasarapu AR, Magliocca KR, Dwivedi B, et al
    Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One. 2020;15:e0238497.
    PubMed     Abstract available

  178. ZHANG W, Xu S, Shi L, Zhu Z, et al
    Construction and analysis of a competing endogenous RNA network to reveal potential prognostic biomarkers for Oral Floor Squamous Cell Carcinoma.
    PLoS One. 2020;15:e0238420.
    PubMed     Abstract available

  179. KIM GH, Min YW, Lee H, Min BH, et al
    Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    PLoS One. 2020;15:e0238113.
    PubMed     Abstract available

  180. GUERREIRO EM, Ovstebo R, Thiede B, Costea DE, et al
    Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    PLoS One. 2020;15:e0238591.
    PubMed     Abstract available

  181. VAN HINTE G, Leijendekkers RA, Te Molder B, Jansen L, et al
    Reproducibility of measurements on physical performance in head and neck cancer survivors; measurements on maximum mouth opening, shoulder and neck function, upper and lower body strength, level of physical mobility, and walking ability.
    PLoS One. 2020;15:e0233271.
    PubMed     Abstract available

  182. PINTO N, Prokopec SD, Ghasemi F, Meens J, et al
    Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.
    PLoS One. 2020;15:e0239315.
    PubMed     Abstract available

  183. ZENG S, Fu L, Zhou P, Ling H, et al
    Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0239586.
    PubMed     Abstract available

  184. BJERKLI IH, Laurvik H, Nginamau ES, Soland TM, et al
    Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report.
    PLoS One. 2020;15:e0239783.
    PubMed     Abstract available

  185. AKRAM F, Koh PE, Wang F, Zhou S, et al
    Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy.
    PLoS One. 2020;15:e0240043.
    PubMed     Abstract available

  186. RZEPAKOWSKA A, Zurek M, Grzybowski J, Kotula I, et al
    Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions.
    PLoS One. 2020;15:e0239550.
    PubMed     Abstract available

  187. PORTO AC, Pinto Blumetti T, Oliveira Santos Filho IDA, Calsavara VF, et al
    Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
    PLoS One. 2020;15:e0240864.
    PubMed     Abstract available

  188. SANIKINI H, Muller DC, Chadeau-Hyam M, Murphy N, et al
    Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
    PLoS One. 2020;15:e0240413.
    PubMed     Abstract available

  189. BRADLEY A, Sami S, N G H, Macleod A, et al
    A predictive Bayesian network that risk stratifies patients undergoing Barrett's surveillance for personalized risk of developing malignancy.
    PLoS One. 2020;15:e0240620.
    PubMed     Abstract available

  190. WONG WY, Gilman K, Limesand KH
    Yap activation in irradiated parotid salivary glands is regulated by ROCK activity.
    PLoS One. 2020;15:e0232921.
    PubMed     Abstract available

  191. NA HY, Moon JH, Choi JY, Yu HW, et al
    Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses.
    PLoS One. 2020;15:e0241597.
    PubMed     Abstract available

  192. RAMASAMY T, Chen X, Qin B, Johnson DE, et al
    STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
    PLoS One. 2020;15:e0242264.
    PubMed     Abstract available

  193. XU S, Li Z, Xu M, Peng H, et al
    The role of carbon nanoparticle in lymph node detection and parathyroid gland protection during thyroidectomy for non-anaplastic thyroid carcinoma- a meta-analysis.
    PLoS One. 2020;15:e0223627.
    PubMed     Abstract available

  194. YOON J, Lee E, Koo JS, Yoon JH, et al
    Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer.
    PLoS One. 2020;15:e0242806.
    PubMed     Abstract available

  195. MUKHERJEE G, Bag S, Chakraborty P, Dey D, et al
    Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
    PLoS One. 2020;15:e0242058.
    PubMed     Abstract available

  196. WONDIMAGEGNEHU A, Hirpa S, Abaya SW, Gizaw M, et al
    Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017.
    PLoS One. 2020;15:e0242807.
    PubMed     Abstract available

  197. YKEMA BLM, Hoefnagel SJM, Rigter LS, Kodach LL, et al
    Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.
    PLoS One. 2020;15:e0243178.
    PubMed     Abstract available

  198. CHUERDUANGPHUI J, Ekalaksananan T, Heawchaiyaphum C, Vatanasapt P, et al
    Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
    PLoS One. 2020;15:e0242465.
    PubMed     Abstract available

  199. OFFICER K, Pruvot M, Horwood P, Denk D, et al
    Epidemiology and pathological progression of erythematous lip lesions in captive sun bears (Helarctos malayanus).
    PLoS One. 2020;15:e0243180.
    PubMed     Abstract available

  200. MU HW, Chen CH, Yang KW, Pan CS, et al
    The prevalence of esophageal cancer after caustic and pesticide ingestion: A nationwide cohort study.
    PLoS One. 2020;15:e0243922.
    PubMed     Abstract available

  201. UCHIDA Y, Tsugawa T, Tanaka-Mizuno S, Noma K, et al
    Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.
    PLoS One. 2020;15:e0244143.
    PubMed     Abstract available

  202. DANSTRUP CS, Marcussen M, Pedersen IS, Jacobsen H, et al
    DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic review.
    PLoS One. 2020;15:e0244101.
    PubMed     Abstract available

  203. KANG SK, Mali RD, Braithwaite RS, Kerr AR, et al
    Point-of-care characterization and risk-based management of oral lesions in primary dental clinics: A simulation model.
    PLoS One. 2020;15:e0244446.
    PubMed     Abstract available

  204. PARK JM, Choi CH, Wu HG, Kim JI, et al
    Correlation of the gamma passing rates with the differences in the dose-volumetric parameters between the original VMAT plans and actual deliveries of the VMAT plans.
    PLoS One. 2020;15:e0244690.
    PubMed     Abstract available

  205. KALISZEWSKI K, Diakowska D, Rzeszutko M, Nowak L, et al
    Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence.
    PLoS One. 2020;15:e0244930.
    PubMed     Abstract available

    January 2019
  206. CHEN WY, Chen TC, Lai SF, Liang TH, et al
    Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.
    PLoS One. 2019;14:e0225962.
    PubMed     Abstract available

  207. ABRAHAM M, Kordatou Z, Barriuso J, Lamarca A, et al
    Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
    PLoS One. 2019;14:e0224540.
    PubMed     Abstract available

  208. FONG PY, Tan SH, Lim DWT, Tan EH, et al
    Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    PLoS One. 2019;14:e0224665.
    PubMed     Abstract available

  209. YAN Z, Zhang J, Long H, Sun X, et al
    Correlation of CT texture changes with treatment response during radiation therapy for esophageal cancer: An exploratory study.
    PLoS One. 2019;14:e0223140.
    PubMed     Abstract available

  210. KELLY A, Barres B, Kwiatkowski F, Batisse-Lignier M, et al
    Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    PLoS One. 2019;14:e0221298.
    PubMed     Abstract available

  211. KRAG AE, Kiil BJ, Hvas CL, Hvas AM, et al
    Effect of remote ischemic preconditioning on hemostasis and fibrinolysis in head and neck cancer surgery: A randomized controlled trial.
    PLoS One. 2019;14:e0219496.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.